Krystal Biotech, Inc.

Krystal Biotech, Inc. is using gene therapy to develop effective and novel treatments for skin diseases. Our goal is to make a meaningful difference in the lives of underserved patient populations with debilitating skin diseases.We work to accomplish that through scientific innovation, operational excellence and believe that “nature operates in the shortest way possible”.We have developed a proprietary gene therapy platform, the Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases for which we believe there are no known effective treatments.

Bank Name Krystal Biotech, Inc.
Stock Exchange NASDAQ
Symbol KRYS
Sector Healthcare
Industry Biotechnology: Biological Products
Country United States
World Region Amarica
Chairman Mr. Krish S. Krishnan
CEO Mr. Krish S. Krishnan
Employees 12
Website www.krystalbio.com
Registered Year 2015

UpdateContent
UpdateContent
UpdateContent